Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06625957
PHASE3

Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition

Sponsor: Yuhan Corporation

View on ClinicalTrials.gov

Summary

A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 versus NTCB-C in patients who require parenteral nutrition

Official title: A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 Versus NTCB-C in Patients Who Require Parenteral Nutrition

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2024-12-04

Completion Date

2025-07-18

Last Updated

2025-01-07

Healthy Volunteers

No

Interventions

DRUG

NTCB02-1

3 Days infusion

DRUG

NTCB-C

3 Days infusion

Locations (5)

National Cancer Center

Gyeonggi-do, Goyang-si, South Korea

Chonnam National University Hwasun Hospital

Jeollanam-do, Hwasun-gun, South Korea

Jeonbuk National University Hospital

Jeollabuk-do, Jeonju-si, South Korea

Severance Hospital

Seoul, Seodaemun-gu, South Korea

Seoul National University Bundang

Gyeonggi-do, Seongnam-si, South Korea